Skip to main content
Premium Trial:

Request an Annual Quote

Private UK Clinic Group to Offer Premaitha Health's Iona Noninvasive Prenatal Test

NEW YORK (GenomeWeb) — Premaitha Health said today that it has partnered with This is My, a private ultrasound and pregnancy screening clinic group in the UK, to offer its Iona noninvasive prenatal test.

Under the agreement, This is My will offer the test at its clinics in Leeds, Manchester, Liverpool, Hull, Coventry, Halifax, Durham, and London.

The Iona test estimates the risk of trisomy 21, 13, 18, and other genetic conditions in a fetus and has a turnaround time of five days. This is My is offering the test on its own for £360 ($570) or combined with an ultrasound for £450 ($710).

Earlier this year, Premaitha signed similar agreements with laboratories in Poland, Switzerland, and the UK.

The Scan

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.

Topical Compound to Block EGFR Inhibitors May Ease Skin Toxicities, Study Finds

A topical treatment described in Science Translational Medicine may limit skin toxicities seen with EGFR inhibitor therapy.

Dozen Genetic Loci Linked to Preeclampsia Risk in New GWAS

An analysis of genome-wide association study data in JAMA Cardiology finds genetic loci linked to preeclampsia that have ties to blood pressure.

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.